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ABSTRACT: 
This article is a case report of a case of diphtheria which presented as diphtheritic tonsillitis in stridor and finally 
succumbed to diphtheritic myocarditis. Here we describe the case presentation, the treatment modalities undertaken, 
and the fatal course of events followed by an elaborate discussion on diphtheria.
INTRODUCTION: 
1,6
No bacterial disease of humans has been as successfully studied as diphtheria. Its history dates back to the times of 
Hippocrates, who first clinically described it in reference to the disease in ancient Syria and Egypt  in the 17
th 
century. By the 18
th century, diptheria reached epidemic proportions in Europe and America. It came to be known as 
“El Garatillo” meaning “the strangler” in Spain and “the gullet disease” in Italy and Sicily. More relevantly to us, 
there seems to be a quiet resurgence of diphtheria in the last few years in our country,  with cases in India, far 
outnumbering those of any other country in the world, according to a report  by the WHO. So are we seeing “ The 
Return of The Strangler” ??
CASE REPORT:
An 18 years old married female patient Valli, hailing from Kanchipuram, was brought by her mother, brother and 
husband to Stanley General Hospital casualty on 30/11/2011 at 12:51am in a state of stridor. On quickly assessing the situation, the medical officers on duty at the causality that night, made an immediate admission and issued a call 
over to the ENT department for further management of the patient. On probing into the details, the patient’s relatives 
gave a history of fever and throat pain for 10 days, and breathlessness for 2 days. The patient had 1
st been taken to 
other hospitals and had finally been referred to us for further management. On examining the patient, we found her 
to be febrile,toxic and in severe stridor. An examination of the oral cavity revealed trismus,an edematous uvula and 
enlarged, congested tonsils covered by a dirty greyish yellow membrane which was more on the right side and 
extending onto the soft palate as well. Removal of this membrane provoked bleeding. The rest of the oropharynx 
could not be visualized.   
The patient’s neck was suggestive of Bullneck.   
An xray neck AP view of the patient showed findings suspicious of a Steeple’s sign with possible narrowing of the 
larynx at the region of the subglottis and proximal tracheal narrowing.
g gThe patient’s relatives did not know about the immunization status of the patient. The patient was admitted, given 
intravenous fluids, parenteral antibiotics and a dose of intravenous steroids in an effort to control the infection and 
the laryngeal edema which could have set in. After doing the basic investigations and taking necessary pre-operative 
preparations, the patient was shifted to the emergency operation theatre for emergency tracheostomy under local 
anaesthesia. After infiltrating the skin with a premixed solution of 2% solution xylocaine with  1 in 80,000 
adrenaline, a midline incision was made below the cricoids cartilage in the Jackson’s triangle. Tracheostomy was 
proceeded with in the usual way, separating the skin and subcutaneous fascia, retracting the strap muscles and 
ishthmus of thyroid. Finally the pre-tracheal fascia was incised and the trachea identified. A tracheal stoma was 
created by removing a tracheal cartilage and a portex cuffed tracheostomy tube inserted to secure the airway with 
stay sutures holding it in place. After ensuring complete heamostasis and an adequate airway, the patient was shifted 
to the ENT ward for observation  and further care. The patient who was initially stable, started developing symptoms 
and signs suggestive of diptheritic myocarditis induced heart block in the next couple of hours with chest pain and a 
declining pulse rate and blood pressure.  Despite our best efforts to revive her, she succumbed to it, and was declared 
dead on  30/11/2011 at 5 10am. Since the suspicion of a diptheritic etiology was held strongly, the operation theatre 
was closed down for the next 12 hours and properly re-sterilized. The anaesthetists, surgeons, staff and workers who 
had thus been exposed to a possible infectious case of diphtheria were given off for the next 5 days in an endeavour 
at isolation, the membrane that has been described previously, had been scraped on the operating table and sent for 
histopathological and microbiological examination for arriving at a diagnosis and the causative agent. Our worst 
fears came true when a report of Corynebacterium diptheriae-gravis type was issued. 
DISCUSSION:
A BRIEF RUN THROUGH HISTORY:
1
The bacterium was first identified by Koch in 1883, and cultivated by Loeffler in 1884.
Roux and Yersin discovered the soluble exotoxin in 1888, while Von Behring and Kitasato came up with 
the antitoxin in 1890. 
In 1909, Theobald and Smith identified the toxin-antitoxin complex, while the Schick test came into 
practice in 1913.
In 1924, Ramon stumbled onto a means to prepare the non-toxic antigenic equivalent of the diphtheria 
toxin( TOXOID), by treating it with formaldehyde.
Freeman in 1951, described the lysogenic nature of the pathogenic (toxigenic) strains of Corynebacterium 
diphtheria.EPIDEMIOLOGY: 
3,1,13,6,5
Under the 2012 ICD-10-CM diagnosis codes, diptheritic tonsillitis comes under code A36.0, which is 
applicable to diptheritic membranous angina and tonsillar diphtheria.
Diphtheria is a contagious disease that can be contracted through direct physical contact, by breathing in 
the aerosolised secretions of infected individuals, and by consuming the milk of infected cows.in endemic 
ares, it is mainly a disease of childhood. It is rare in the first year of life, due to passive immunity received 
from the mother, reaches a peak between 2-5 years of age and then gradually declines in its incidence. 
Asymptomatic carriers are the most important source of infection.  Once considered to be a dreaded 
disease, it has now been brought well under control largely due to active efforts at mass immunization 
coverage. This is well reflected by the statistical data of countries worldwide. For example, if we take the 
United States, there were 150,000 cases and 13,000 deaths due to diphtheria in the 1920s. Vigorous 
immunization brought down this rate to 19,000 in the 1945. There were 196 cases/year between 1970-1979. 
However between 1980-2004, there were just 57 cases of diphtheria. An  outbreak of diphtheria occurred in 
Russia during the early 1990s with 50,425 cases reported in 1995, at a yearly rate of 17.3 cases/100,000 
persons. Mass immunization, early identification and appropriate treatment of these cases, has reduced this 
rate to 0.6 cases/100,000 persons since 1999. There were 3978 reported cases to the WHO in 2006. 
However the recent trend in the Indian statistics has been alarming. According to the National Health 
Profiles released by the Central Bureau of Health Intelligence under the Directorate General of Health 
Services, the total number of diphtheria cases in India in 2006 was 2834, 3354 in 2007 and 6081 in 2008 
(with 65 deaths). Even as recent as the WHO’s Health Statistics,2009, India ranks highest in the world with 
respect to the number of diphtheria cases. The problem seems to lie in inadequate immunization coverage 
with the triple antigen DPT, which is only 50-60%. It needs to become a 100% to achieve disease 
eradication. 
  










The name is derived from the tough leathery pseudomembrane formed in the disease. (diptheros, meaning 
leather). These are slender rods (bacilli) with a tendency to clubbing at one or both ends. They are non 
sporing, nonmotile and non capsulated, Gram positive bacilli. 
Metachromatic granules ( volutin or Babes Ernst granules) composed of polymetaphosphate are seen in 
the cells, which are more gram positive than the rest of the bacterial cell. They are often situated at the 
poles of the bacilli and hence called polar bodies. They can be demonstrated clearly with special stains 
such s Albert’s, Neisser’s and Ponder’s. the bacilli are arranged in a characteristic Chinese letter or 
Cuneiform pattern in smears due to incomplete separation on daughter cells after binary fission. This is an 
Albert’s stain stained microscopic picture of the diptheria bacillus.  
Media commonly used for cultivation are Loeffler’s serum slope and tellurite blood agar. Diphtheria bacilli 
grow very rapidly on Loeffler’s serum slope,and colonies can be seen in 6-8 hours. Tellurite(0.04%) 
inhibits the growth of most other bacteria, acting as a selective agent. Diphtheria bacilli reduce tellurite to 
metallic tellurium giving the colonies a gre or black colour. Based on the colonial morphology on tellurite 
medium and other properties, McLeod classified diphtheria bacilli into 3 types- gravis, intermedius and 
mitis, of which gravis causes the most severe form of disease, mitis the mildest and intermedius , a disease 
of intermediate severity. The gravis and intermedius types are associated with high case fatality rates(5-10%), reaching upto 20% fatality rate in the age groups less than 5 years and more than 40 years. Only the 
gravis types is positive for glycogen and starch fermentation.
Virulent strains of diphtheria produce a very powerful exotoxin(protein). The pathogenic effects of the 
bacilli are due to the exotoxin. It consists of two fragments, A & B. All the enzymatic activity is present on 
fragment A, while fragment B is responsible for binding the toxin to the cell. The toxigenecity depends on 
the presence of corynephages. The toxigenecity remains only as long as the bacilli is lysogenic. The 
diphtheria toxin acts by inihibiting protein synthesis. Specifically, fragment A inhibits polypeptide chain 
elongation in the presence of NAD, by inactivating the elongation factor EF2. 
PATHOGENECITY:
2,3,5,7,14
The incubation period is commonly 3-4 days. The site of infection may be 1. Faucial, 2. Laryngeal, 3.nasal, 
4.otitic, 5.conjunctival, 6. Genital- vulval, vaginal or prepucial, 7. Cutaneous.  Faucial diphtheria is the 
commonest type. According to clinical severity, diphtheria may be classified as 1. Malignant or 
hypertoxic, with marked adenitis(bullneck), where death is due to acute circulatory failure,2. Septic and 3. 
Haemorrhagic. The common complications are asphyxia, acute circulatory failure,  post diptheritic 
paralysis ( palatine and ciliary but not papillary, where spontaneous recovery is the rule) and sepsis 
( pneumonia and otitis media). On an anatomical basis and in an ascending order of severity from mild to 
severe, clinical types can be arranged as follows:
Nasal- involvement of the anterior nares- little toxin absorption.
Tonsillar- membrane on one or both tonsils- moderate tonsil absorption.
Pharyngeal- membrane on the posterior wall or fauces- moderately severe toxin absorption.
Nasopharyngeal- involvement of the mucous membrane of the posteror nares, upper pharynx and tonsils- 
toxin absorption severe.
Laryngeal- ( three types):
Primary- sole involvement of the larynx- toxin absorption minimal.
Tracheobronchial- involvement of the trachea,bronchi, smaller bronchioles and occasionally 
alveoli- toxin absorption moderate.
Mixed-  involvement of the larynx plus extension downwards and upwards to involve the other 
structures as well. Toxin absorption will depend upon the extent of involvement of non-laryngeal structures.
Diptheritic tonsillitis differs from acute follicular tonsillitis in that it occurs in unimmunized individuals, 
causing low grade fever, severe toxic symptoms, bullneck, neurological deficits and albuminuria. The 
organism will be demonstrable by special stains. 
The Steeple sign and tracheal narrowing seen in this patient’s X-ray neck AP view, re-establishes the fact 
that though croup(acute laryngotracheobronchitis) is the primary diagnosis to be considered in patients with 
such radiological findings,other differential diagnoses such as epiglottitis, bacterial tracheitis, foreign body, 
diphtheria, retropharyngeal abscess, peritonsillar abcess and asthma should also be borne in mind while 
evaluating such patients. 
DIPTHERITIC MYOCARDITIS:
8,9,10,11,12,13. diptheritic myocarditis has an associated mortality rate of 60%, and it accounts for majority of the deaths 
related to diphtheria. Diphtheria causes disturbances in impulse formation and conduction. The diphtheria 
toxin causes severe acute myocarditis leading onto cardiac damage. Risk factors for cardiac involvement in 
diphtheria: older age, low socio-economic status, extensive involvement of the respiratory tract. A study by 
Nalmas et al, states that the risk of cardiac damage is higher in patients with fever, toxic disease and 
membranous disease. The ECG findings associated with diptheritic myocarditis include PR interval 
prolongation and T wave changes in asymptomatic individuals, and intraventricular blocks and AV blocks 
in symptomatic patients. A complete AV block is the most ominous ECG finding. The pointers for a bad 
prognosis in diptheritic myocarditis: ventricular ectopics on presentation, WBC count >25,000 
cells/microL, aspartate transaminase > 80U/L ( serum transaminase levels provide valuable diagnostic and 
prognostic information in diptheritic myocarditis) and membrane extending to atleast 2 anatomical sites. 
Minh Dung et al have conducted a study to assess the usefulness of temporary insertion of a cardiac 
pacemaker in the treatment of severe diptheritic myocarditis and found that it helped to improve the 
outcome even in the face of complete heart block.
TREATMENT:
3,14
A patient with suspected or confirmed diphtheria, should be hospitalized immediately,isolated and hydrated 
adequately with intravenous fluids. The recommended duration of isolation for patients with diphtheria is 
about 7-10 days. The exceptions being the nasopharyngeal and laryngeal forms, in which case, the patient 
should be hospitalized for a minimum duration of 42 days. This stay can be appropriately extended 
depending on the course of the disease and any complications that the patient may develop. Contacts may 
be isolated for a period creesponding to the incubation period of the disease. Antitoxin should be 
administered as early as possible. It forms  the main anchor of treatment for diphtheria. The dictim still 
holds good that the prognosis in diphtheria depends largely on the first day the antitoxin is administered. 
This is because the antitoxin can neutralize only the circulating toxin. It becomes useless once the toxin 
gets fixed to the tissues. Of the total dose of antitoxin being administered, half should be given by 
intravenous route, and the other half by intramuscular route. The recommended dose of antitoxin for the 
various forms of diphtheria are as follows:
Nasal – 10,000 to 20,000 units
Laryngeal/Pharyngeal – 20,000 to 40,000 units.
Tonsillar – 15,000 to 25,000 units.
Combined type/delayed diagnosis – 40,000 to 60,000 units.
Severe disease (extensive disease/ more than 3 days duration/ neck edema/ 
collapse/breathlessness) – 80,000 to 100,000 units.
Carrier/Contact – not required.Though they cannot replace the role of the antitoxin, antibiotics are necessary and useful adjuncts in the 
treatment of diphtheria. They can be used to for patients as well s carriers in an attempt to eradicate the 
diphtheria bacillus and prevent its transmission. The recommended antibiotics are:
a) Procaine Penicillin G given intramuscularly for 14 days.
b) Erythromycin (in  dose of 40mg/kg with a maximum of 2g/day) given orally for 14days.
In case of allergy to Penicillin and Erythromycin,Rifampicin or Clindamycin can be used.
Carnitine 100mg/kg/day BD for 4 days may help prevent myocarditis.a
In case of complications in the form of airway obstruction, tracheostomy or intubation may be 
considered appropriate to the situation and disease presentation.
PROPHYLAXIS:
3,4,14,15,16
Diphtheria vaccine for children is combined with tetanus and acellular pertussis and given as a triple 
vaccine known as DTaP (diphtheria, tetanus, acellular pertussis). DTaP should be given at two, four and six 
months of age,next at 15 to 18 months, and finally between four and six years.The guidelines given in the 
Indian National Immunization Schedule direct the primary course of DPT vaccine ( containing whole cell 
pertussis component) to be given at 6,10 and 14 weeks of age, a booster dose between 16-24 months, DT at 
5-6 years and lastly TT at 10 and 16 years.
In 2005, a new vaccine was approved as single booster vaccination for adolescents and adults called Tdap 
(tetanus, diphtheria and acellular pertussis). The recommended age for Tdap vaccination is 11 to 12 years. 
Td (tetanus and diphtheria) vaccine can also be used as booster dose in adolescents and adults. It does not 
contain the pertussis component.
Adults aged between 19 and 64 years should receive a single dose of Tdap to replace a single dose of Td 
for active booster vaccination if they received their last dose of Td more than ten years earlier. Thereafter, 
Td should be given every ten years to maintain immunity. 
Persons who have been exposed to patients with diphtheria, may be given vaccine prophylaxis depending 
on their immunization status: booster vaccine if they have already completed the primary course of 
diphtheria vaccine, or the full primary course of 3 vaccine doses if they have not been immunized 
previously, apart from appropriate anti-microbial prophylaxis. In fact it has also been recommended that the 
patients themselves receive diphtheria prophylaxis in the convalescence period, as the disease is not known 
to give life-long immunity.
A recent article by the Advisory Committee on Immunization Practices (ACIP) on the Immunization of 
Health-Care Professionals has recommended that all Health-Care Professionals receive a single dose of Tdap as soon as feasible, if they have not previously received it, regardless of age (as pre-exposure 
prophylaxis).
Recommended Principles of post-exposure prophylaxis for Health-Care Professionals: (based on a 
‘Exposure Management Infectious Diseases: Healthcare Personnel (Hep)’ policy adopted by the University 
of Toledo last year)
1.Nasopharyngeal cultures will be obtained from exposed personnel.  These HCP will be monitored for 
signs and symptoms of  diphtheria for seven (7) days after exposure. 
2.  Antimicrobial prophylaxis will be administered to personnel who have contact with respiratory droplets 
or cutaneous lesions of  patients infected with diphtheria. 
3.  Previously immunized exposed personnel will be immunized with Tdap. 
4. Exposed personnel will have nasopharyngeal cultures repeated at least two (2) weeks after 
completion of antimicrobial therapy. Those who remain culture positive will receive repeat antimicrobial 
therapy.
CONCLUSION: 
This incident is a wake up call for us to sit up and take notice of this re-emerging dangerous disease, and 
take appropriate steps to bring the situation under control. Widespread complete immunization coverage 
should be the modus operandi as it greatly helps in nipping the problem in the bud. There are lessons to be 
learnt and technological/medical advancements to be made in the early identification and management of 
diptheritic myocarditis. Public awareness is another area to be addressed, so that they identify the 
symptoms and seek medical attention as early as possible. Efforts should be taken to ensure that the 
necessary treatment methods and preventive measures are available at every level of the health care 
delivery system, as, this disease, though highly contagious and threatening on one hand, is highly amenable 
to control and eradication if we act quickly and consistently.REFERENCES:
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